Antidote

Antidote is a digital health company on a mission. Their aim is to accelerate the breakthroughs of potentially life-saving treatments, by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of awareness, Antiodte is a digital health company on a mission. Their aim is to accelerate the breakthroughs of potentially life-saving treatments, by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of awareness, Antidote uses cutting-edge technology to match the right patients with the right trials." Antidote uses cutting-edge technology to match the right patients with the right trials.

Contact information:

Programs

What Treatment Options Are Available for Lung Cancer Patients With No Driver Mutations?

Dr. Alex Spira, Dr. Bruce Johnson and lung cancer patient Don Stranathan discuss how lung cancer patients can get tomorrow’s medicine today.

Published:

The Importance of Communicating With Your Lung Cancer Oncologist

Drs. Alex Spira, Bruce Johnson and patient advocate Matt Ellefson discuss how lung cancer patients can get tomorrow’s medicine today. Watch now to learn more.

Published:

Actionable Tips From a Lung Cancer Survivor

Drs. Alex Spira, Bruce Johnson and patient advocate Matt Ellefson discuss how lung cancer patients to get tomorrow’s medicine today. Watch now to learn more.

Published:

Should I Consider a Clinical Trial If I Have Lung Cancer?

Drs. Alex Spira, Bruce Johnson and patient advocate Matt Ellefson discuss how lung cancer patients to get tomorrow’s medicine today. Watch now to learn more.

Published:

Comprehensive Diagnostic Testing From a Lung Cancer Patient’s Perspective

Matt Ellefson of SURVIVEiT helps lung cancer patients make decisions on obtaining broader panel testing. Watch now to hear his expert advice.

Published:

Expert Advice on Genetic Testing for Lung Cancer Patients

When to get genetic testing for lung cancer and who should be profiled. Listen to expert analysis with Drs. Bruce E. Johnson and Alex Spira.

Published:

The Proactive Lung Cancer Patient: How to Get Tomorrow’s Medicine Today

Drs. Alex Spira, Bruce Johnson and patient advocate, Matt Ellefson, discuss how lung cancer patients to get tomorrow’s medicine today. Watch now to hear their expert advice.

Published:

Can Lung Cancer Patients Be the Engine for Driving Molecular Testing?

A candid conversation with SURVIVEiT’s Matt Ellefson on finding the best treatment for lung cancer. Tune in now for his expert perspective.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 28, 2019